Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Molecular Buys Software Tool Developer

Premium

OXFORD, UK--Oxford Molecular Group here acquired international software tool developer Chemical Design and its Chem-X software to increase Oxford's product offerings in chemoinformatics, molecular design, and combinatorial chemistry. Chem-X used by some companies in combination with Oxford's RS3 Discovery product, is licensed to over 700 users worldwide on Windows NT and Unix platforms. Oxford Molecular also said it plans to tailor Chem-X and RS3 Discovery to provide more flexible systems and to leverage the combination of technologies. The acquisition will extend the company's capabilities in the areas of library registration, robotics integration, and library design.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.